Tekla Capital Management’s Halozyme HALO Stock Holding History

Tekla Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-69,917	Closed	-$1.87M	–	211
2020 Q2	$1.87M	Hold	69,917	–	–	0.07%	165
2020 Q1	$1.26M	Buy	+69,917	New	+$1.33M	0.06%	163
2017 Q2	–	Sell	-200,000	Closed	-$2.59M	–	147
2017 Q1	$2.59M	Hold	200,000	–	–	0.1%	102
2016 Q4	$1.98M	Hold	200,000	–	–	0.08%	110
2016 Q3	$2.42M	Hold	200,000	–	–	0.09%	112
2016 Q2	$1.73M	Hold	200,000	–	–	0.07%	135
2016 Q1	$1.89M	Hold	200,000	–	–	0.08%	122
2015 Q4	$3.47M	Buy	+200,000	New	+$3.19M	0.13%	103

Other funds holding HALO

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Tekla Capital Management's HALO Position: Q3 2020 in Review

Tekla Capital Management sold out of Halozyme (HALO) in Q3 2020, closing a stake of 69,917 shares — an estimated $1.87M sold.

Tekla Capital Management first reported a position in HALO in Q4 2015 and held it in 8 quarters. The position peaked at $3.47M in Q4 2015. 268 funds tracked by Wall St. Rank hold HALO as of Q3 2020.

Tekla Capital Management reported no remaining Halozyme position as of Q3 2020 after selling out during the quarter.
Tekla Capital Management sold 69,917 Halozyme shares in Q3 2020, an estimated $1.87M.
Tekla Capital Management first reported a position in Halozyme in Q4 2015 and held it in 8 quarters.
Tekla Capital Management's Halozyme position peaked at $3.47M in Q4 2015.
268 funds tracked by Wall St. Rank held Halozyme as of Q3 2020.

Based on Tekla Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.